High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.
作者信息
Helgeland A, Hjermann I, Leren P, Enger S, Holme I
出版信息
Br Med J. 1978 Aug 5;2(6134):403. doi: 10.1136/bmj.2.6134.403.
Abstract
摘要
相似文献
1
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.高密度脂蛋白胆固醇与抗高血压药物：奥斯陆研究
Br Med J. 1978 Aug 5;2(6134):403. doi: 10.1136/bmj.2.6134.403.
2
HDL-cholesterol in antihypertensive treatment. The Oslo Study.高血压治疗中的高密度脂蛋白胆固醇。奥斯陆研究。
Acta Med Scand Suppl. 1979;625:131-4. doi: 10.1111/j.0954-6820.1979.tb00757.x.
3
Antihypertensive drugs and blood lipids: the Oslo study.抗高血压药物与血脂：奥斯陆研究
J Cardiovasc Pharmacol. 1982;4 Suppl 2:S222-4.
4
5
The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia.普萘洛尔治疗及蛋白尿在肾移植术后高脂血症病因学中的作用。
Clin Nephrol. 1982 Aug;18(2):95-100.
6
7
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.缬沙坦分别与氨氯地平或氢氯噻嗪固定剂量复方制剂对高血压患者脂蛋白亚组份谱的不同影响。
J Hum Hypertens. 2013 Jan;27(1):44-50. doi: 10.1038/jhh.2011.108. Epub 2011 Dec 1.
9
10
Variability in plasma lipoprotein profiles when comparing diltiazem and propranolol.比较地尔硫䓬和普萘洛尔时血浆脂蛋白谱的变异性。
Ann Pharmacother. 1993 Sep;27(9):1048-52. doi: 10.1177/106002809302700906.
引用本文的文献
1
Goals of antihypertensive therapy.抗高血压治疗的目标。
Drugs. 1995 Feb;49(2):161-75. doi: 10.2165/00003495-199549020-00002.
2
Effect of pindolol on serum lipids and lipid metabolizing enzymes.吲哚洛尔对血脂及脂质代谢酶的影响。
Br J Clin Pharmacol. 1982;13(Suppl 2):445S-447S. doi: 10.1111/j.1365-2125.1982.tb01955.x.
3
Antihypertensive drugs and blood lipids: the Oslo study.抗高血压药物与血脂：奥斯陆研究
Br J Clin Pharmacol. 1982;13(Suppl 2):441S-444S. doi: 10.1111/j.1365-2125.1982.tb01954.x.
4
Effects of pindolol and metoprolol on plasma lipids and lipoproteins.吲哚洛尔和美托洛尔对血脂及脂蛋白的影响。
Br J Clin Pharmacol. 1982;13(Suppl 2):435S-439S. doi: 10.1111/j.1365-2125.1982.tb01953.x.
5
The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.普萘洛尔、阿替洛尔和拉贝洛尔对正常受试者安替比林动力学的短期影响。
Br J Clin Pharmacol. 1982 Jun;13(6):817-20. doi: 10.1111/j.1365-2125.1982.tb01872.x.
6
Oxprenolol, methyldopa and lipids in diabetes mellitus.糖尿病患者中的氧烯洛尔、甲基多巴与脂质
Br J Clin Pharmacol. 1982 Feb;13(2):219-22. doi: 10.1111/j.1365-2125.1982.tb01360.x.
7
Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977.使用抗高血压药物的受试者的血脂和血糖浓度：1977年芬马克郡研究
J Epidemiol Community Health. 1983 Jun;37(2):141-4. doi: 10.1136/jech.37.2.141.
8
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.短期β-肾上腺素能受体阻滞剂对高血压或冠状动脉疾病患者血脂和脂蛋白的影响。
Br Heart J. 1984 Jun;51(6):589-94. doi: 10.1136/hrt.51.6.589.
9
Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.高血压患者血小板黏附和聚集增加：阿替洛尔的作用。
Br J Clin Pharmacol. 1983 Dec;16(6):663-8. doi: 10.1111/j.1365-2125.1983.tb02238.x.
10
Thiazides, beta blockers and lipoproteins.噻嗪类利尿剂、β受体阻滞剂与脂蛋白
Postgrad Med J. 1983 Aug;59(694):483-8. doi: 10.1136/pgmj.59.694.483.
本文引用的文献
1
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.通过用聚阴离子沉淀从人血清中分离脂蛋白的快速方法。
J Lipid Res. 1970 Nov;11(6):583-95.
2
Possible metabolic side effects of beta-adrenergic blocking drugs.β-肾上腺素能阻断药物可能的代谢副作用。
Br Med J. 1978 Apr 1;1(6116):828. doi: 10.1136/bmj.1.6116.828.
3
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.未经治疗和接受噻嗪类药物治疗的轻度高血压患者的血清甘油三酯和血清尿酸。奥斯陆研究。
Am J Med. 1978 Jan;64(1):34-8. doi: 10.1016/0002-9343(78)90177-8.
4
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.血浆高密度脂蛋白浓度与缺血性心脏病的发生
Lancet. 1975 Jan 4;1(7897):16-9. doi: 10.1016/s0140-6736(75)92376-4.
5
Metabolic effects of beta-adrenoreceptor blockers.β-肾上腺素能受体阻滞剂的代谢效应
Drugs. 1976;11 SUPPL 1:121-6. doi: 10.2165/00003495-197600111-00027.
Zotero 插件